Diclofenac sodium gel therapy as an alternative to actinic cheilitis
- 305 Downloads
Actinic cheilitis (AC) is a potentially malignant lesion caused by prolonged exposure to ultraviolet light. The aim of this research was to analyze the efficacy of diclofenac sodium 3% gel in the treatment of this condition, through clinical follow-up.
Thirty-one patients diagnosed with AC were instructed to perform a topical application of the gel three times a day for a period of 90 days. In each visit, a digital photography was obtained for verified progress and response to treatment. Two researchers evaluated all images after treatment was completed and assigned the following scores regarding clinical aspect of the lip: 1, complete improvement; 2, partial improvement; 3, no changes; 4, worsening of the clinical condition. In addition, the patients’ tolerability to the drug and their satisfaction after treatment were evaluated.
Twelve cases abandoned the treatment for reasons unrelated to the study. Ten participants showed total remission of all clinical features of the lesion and three had partial improvement of the characteristics. One participant presented worsening of clinical condition, and in five cases, treatment was discontinued due to development of mild adverse effects at the site of gel application. Regarding satisfaction analyses and tolerability to the drug, from 14 patients who completed treatment without adverse effects or complications, most agreed fully that they were satisfied with the therapy (n = 11) and that the drug was not irritating to the mouth (n = 9). Patients are being monitored without clinical signs of recurrence and/or progression of the lesions.
Topical application of the drug has provided a convenient and well tolerated in most cases.
Diclofenac sodium gel (3%) may be a promising alternative for treatment of actinic cheilitis.
KeywordsCheilitis Diclofenac Cyclooxygenase-2 Cyclooxygenase inhibitors
The work was supported by the Department of Oral–Federal University of Rio Grande do Norte.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of the Federal University of Rio Grande do Norte (Protocol 1.024.559).
Informed consent was obtained from all individual participants included in the study.
- 27.Wang Z, Liu J, Liu HB, Ye M, Zhang YF, Yang DS (2014) Abnormal COX2 protein expression may be correlated with poor prognosis in oral cancer: a meta-analysis. Biomed Res Int 2014:1–9Google Scholar
- 31.Trinchieri G (2011) Innate inflammation and cancer: is it time for cancer prevention? Med Rep F1000:3–11Google Scholar